SPL 1.03% 9.8¢ starpharma holdings limited

Ann: Starpharma and Medicxi Partnership Petalion Therapeutics, page-15

  1. 15,627 Posts.
    lightbulb Created with Sketch. 5706
    is this the blackout reason?

    Imagine if it was @WBA ... a pathetic deal like this surely isn't what insiders hid behind while the share price was at all time lows .... agree @sarge17 - ditching some of my trading parcels purchased a few weeks ago as outlined in Post #:73075649 .... this is just another research agreement that could end up going nowhere and it appears to be all they could get on the back of the phase 2 DEP trials IMO

    ..... always happy for management to surprise me with an actual DEP license deal that pays the company a huge upfront payment but based on this announcement today and the company now flogging a conference call to tout this deal it's not looking likely anything else is in the pipeline ?
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.8¢
Change
0.001(1.03%)
Mkt cap ! $40.90M
Open High Low Value Volume
9.9¢ 10.5¢ 9.7¢ $22.92K 232.2K

Buyers (Bids)

No. Vol. Price($)
1 236173 9.8¢
 

Sellers (Offers)

Price($) Vol. No.
10.0¢ 50800 2
View Market Depth
Last trade - 16.10pm 18/09/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.